Senores Pharmaceuticals Ltd.

SENORES

₹532.9

1.36% (7.15)

Market Cap

₹2,455 Cr.

P/E

41.92

About

Senores Pharmaceuticals is a global research-driven company specializing in developing and manufacturing a wide range of generic pharmaceutical products for the B2B segment. They focus on regulated ma… Read more

Senores Pharmaceuticals is a global research-driven company specializing in developing and man… Read more

Low

435

52W Range

High

665

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

4 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has been buying shares from the open market over last 90 days
Revenue Recognition

Company is converting accounting profit to cash
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Company has made significant capex which might be affecting its roce
ROE

Roe has decreased vs 10 year trend
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
Current vs Historic Valuation

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data
Margin Stability

Unable to calculate due to limited data
ROCE Strength

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

Number of ANDA's Approved (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

FAQs on Senores Pharmaceuticals Ltd. Business

What does Senores Pharmaceutic do?

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.

Who are the competitors of Senores Pharmaceutic?

Senores Pharmaceutic major competitors are Ajanta Pharma, Alembic Pharma, Caplin Point Lab, Gland Pharma, Strides Pharma Scien, Indoco Remedies, IOL Chem & Pharma.
Market Cap of Senores Pharmaceutic is ₹2,455 Crs.
While the median market cap of its peers are ₹15,913 Crs.

Is Senores Pharmaceutic financially stable compared to its competitors?

Senores Pharmaceutic seems to be less financially stable compared to its competitors.
Altman Z score of Senores Pharmaceutic is 4.58 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May	Dec
Investor Presentation	May
Conference Call	Mar	Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Senores Pharmaceuticals Ltd.